Portfolio company
Neurowyzr
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops digital neuroscience assessment tools to screen for early brain decline in healthcare patients and corporate employees.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Neu Health
This company develops a digital neurology platform for Parkinson's disease and dementia patients and clinicians to monitor symptoms and manage care remotely.
MindAhead
This company develops a digital therapy application for individuals with mild cognitive impairment and dementia to slow cognitive decline.
Mindmore
This company provides a digital platform for automated cognitive testing to healthcare clinics and patients with conditions affecting brain function.
BrainCheck
This company develops digital cognitive assessment and care planning software for healthcare providers, health systems, and dementia care management organisations.
Neurotrack
Neurotrack develops digital cognitive assessment tools and health programmes for healthcare providers and pharmaceutical companies to detect and manage Alzheimer's disease.
NyraHealth
This company develops AI-powered speech and memory therapy software for neurological patients, clinics, and therapeutic practices.
neuroClues
This company develops portable eye-tracking medical devices and AI software for clinicians to identify neurological disorders through ocular biomarkers.
Kneu Health
This company develops a smartphone-based platform that tracks motor, speech, and cognitive symptoms for patients with Parkinson’s and dementia and their clinicians.